Yttrium-90 radioembolization in the management of liver malignancies.
Primary and secondary liver tumors are common. Locoregional therapies are establishing a role in the management of liver tumors due to the limited roles of surgical and systemic therapies. Our review presents some general concepts associated with yttrium-90 radioembolization and its specific utilization in various primary and secondary liver malignancies.
Riaz
Ahsun
A
Department of Radiology, Division of Interventional Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA.
Kulik
Laura M
LM
Mulcahy
Mary F
MF
Lewandowski
Robert J
RJ
Salem
Riad
R
D006801:Humans; D008113:Liver Neoplasms / Q000532:radiotherapy*; D019275:Radiopharmaceuticals / Q000008:administration & dosage*; D011878:Radiotherapy / Q000379:methods*; D015021:Yttrium Radioisotopes / Q000008:administration & dosage*
D019275:Radiopharmaceuticals; D015021:Yttrium Radioisotopes